ACLARION INC (ACON) Stock Overview
USA - NASDAQ:ACON - US6551874091 - Common Stock
ACON Key Statistics, Chart & Performance
The current stock price of ACON is 7.72 USD. In the past month the price increased by 7.78%. In the past year, price decreased by -99.55%.
ACON Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.1 | 45.31B | ||
| DOCS | DOXIMITY INC-CLASS A | 47.67 | 13.30B | ||
| WAY | WAYSTAR HOLDING CORP | 33.66 | 6.51B | ||
| HTFL | HEARTFLOW INC | N/A | 2.77B | ||
| CERT | CERTARA INC | 23.02 | 1.81B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 11.97 | 1.46B | ||
| PHR | PHREESIA INC | N/A | 1.45B | ||
| SDGR | SCHRODINGER INC | N/A | 1.37B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.36B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 1.06B | ||
| CTEV | CLARITEV CORP | N/A | 1.01B |
Related stock screener links
About ACON
Company Profile
Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. The company is headquartered in Broomfield, Colorado and currently employs 6 full-time employees. The company went IPO on 2022-04-22. The firm leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The firm has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
Company Info
ACLARION INC
8181 Arista Place, Ste 100
Broomfield COLORADO US
Employees: 6
Phone: 18332752266
ACLARION INC / ACON FAQ
What is the stock price of ACLARION INC today?
The current stock price of ACON is 7.72 USD. The price increased by 3.62% in the last trading session.
What is the ticker symbol for ACLARION INC stock?
The exchange symbol of ACLARION INC is ACON and it is listed on the Nasdaq exchange.
On which exchange is ACON stock listed?
ACON stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ACLARION INC stock?
7 analysts have analysed ACON and the average price target is 20.4 USD. This implies a price increase of 164.25% is expected in the next year compared to the current price of 7.72. Check the ACLARION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ACLARION INC worth?
ACLARION INC (ACON) has a market capitalization of 4.48M USD. This makes ACON a Nano Cap stock.
How many employees does ACLARION INC have?
ACLARION INC (ACON) currently has 6 employees.
What are the support and resistance levels for ACLARION INC (ACON) stock?
ACLARION INC (ACON) has a support level at 7.69 and a resistance level at 7.73. Check the full technical report for a detailed analysis of ACON support and resistance levels.
Is ACLARION INC (ACON) expected to grow?
The Revenue of ACLARION INC (ACON) is expected to grow by 100% in the next year. Check the estimates tab for more information on the ACON EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ACLARION INC (ACON) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ACON, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ACON, evaluating the profitability, health, valuation and growth aspects
- ACLARION INC (ACON) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ACLARION INC (ACON) Sales and EPS estimates to see what analysts future expectations are.
- ACLARION INC (ACON) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ACLARION INC (ACON) Insider and Institutional Ownership to learn about the owners and their transactions.
- ACLARION INC (ACON) Stock Chart to make your own analysis
- ACLARION INC (ACON) Latest news and press-releases to stay up to date.
Does ACLARION INC (ACON) stock pay dividends?
ACON does not pay a dividend.
What is the Price/Earnings (PE) ratio of ACLARION INC (ACON)?
ACLARION INC (ACON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2155.52).
What is the Short Interest ratio of ACLARION INC (ACON) stock?
The outstanding short interest for ACLARION INC (ACON) is 2.49% of its float. Check the ownership tab for more information on the ACON short interest.
ACON Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to ACON. When comparing the yearly performance of all stocks, ACON is a bad performer in the overall market: 96.88% of all stocks are doing better.
ACON Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACON. While ACON has a great health rating, there are worries on its profitability.
ACON Financial Highlights
Over the last trailing twelve months ACON reported a non-GAAP Earnings per Share(EPS) of -2155.52. The EPS increased by 93.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.85% | ||
| ROE | -49.76% | ||
| Debt/Equity | 0 |
ACON Forecast & Estimates
7 analysts have analysed ACON and the average price target is 20.4 USD. This implies a price increase of 164.25% is expected in the next year compared to the current price of 7.72.
For the next year, analysts expect an EPS growth of 99.81% and a revenue growth 100% for ACON